^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GVAX leukemia vaccine

    i
    Other names: GVAX leukemia vaccine, GVAX AML vaccine, GM-CSF producing autologous tumor cell vaccine
    Associations

    News

    Trials
    Company:
    Dana-Farber Cancer Institute, Novartis
    Drug class:
    Immunostimulant, GM-CSF agonist
    Related drugs:
    Associations

    News

    Trials
    3years
    GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized double blinded phase 2 trial. (PubMed, Blood Adv)
    GVHD prophylaxis included tacrolimus and methotrexate. GVAX does not improve survival after HSCT for MDS/AML. (Clinicaltrials.gov identifier: NCT01773395).
    Clinical • P2 data • Journal
    |
    CSF2 (Colony stimulating factor 2)
    |
    methotrexate • GVAX leukemia vaccine